Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rac1/pSTAT3 expression during initiation of thiopurine therapy in adult IBD
NL-OMON51798Recruiting
- Sponsor
- Zuyderland
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of azathioprine and mercaptopurine in Crohn's disease and autoimmune colitis, sponsored by Zuyderland. Primary endpoint: Intra-individual differences in Rac1 and pSTAT3 expression. Started Jun 2022; status: recruiting.
02
Drugs
azathioprinemercaptopurine
03
Conditions
Crohn's diseaseautoimmune colitis
Beyond the preview
Go deeper on NL-OMON51798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51798.